IT-29 * IMMUNE CHECKPOINT BLOCKADE FOR GLIOBLASTOMA: PRECLINICAL ACTIVITY OF SINGLE AGENT AND COMBINATORIAL THERAPYDavid A. Reardon, Gordon J. Freeman, Keith L. Ligon et al.|Neuro-Oncology|2014Cited by 4